← All Kineta, Inc/de filings

Kineta, Inc/de 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

KANT
Kineta, Inc/de
10-Q: Kineta, Inc. Faces Going Concern Uncertainty Amidst Strategic Review and Proposed Merger with TuHURA Biosciences
Kineta, Inc. reports Q1 2025 results while navigating strategic alternatives, including a proposed merger with TuHURA Biosciences, amidst substantial doubt about its ability to continue as a going concern.
KANT
Kineta, Inc/de
10-Q: Kineta Inc. Reports Q3 2024 Results Amid Strategic Review and Financial Uncertainty
Kineta Inc. released its Q3 2024 financial results, highlighting ongoing strategic review efforts and significant financial challenges, including a going concern warning.
KANT
Kineta, Inc/de
10-Q: Kineta Inc. Faces Going Concern Issues Amidst Failed Funding and Strategic Review
Kineta Inc. is exploring strategic alternatives, including a potential sale or liquidation, due to substantial doubt about its ability to continue as a going concern after a private placement funding failed.
KANT
Kineta, Inc/de
10-Q: Kineta Inc. Faces Going Concern Uncertainty After Private Placement Collapse, Explores Strategic Options
Kineta Inc. is exploring strategic alternatives, including a potential sale or liquidation, after a private placement funding fell through, raising substantial doubt about its ability to continue as a going concern.